Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 682018, 9 pages
http://dx.doi.org/10.1155/2012/682018
Research Article

Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus

1Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL 60637, USA
2Section of Rheumatology and Rush Lupus Clinic, Rush University, Chicago, IL 60612, USA
3Section of Genetic Medicine, University of Chicago, Chicago, IL 60637, USA

Received 15 June 2012; Accepted 17 July 2012

Academic Editor: George N. Goulielmos

Copyright © 2012 Yelena Koldobskaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Moser, J. A. Kelly, C. J. Lessard, and J. B. Harley, “Recent insights into the genetic basis of systemic lupus erythematosus,” Genes and Immunity, vol. 10, no. 5, pp. 373–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Ko, B. S. Franek, M. Marion, K. M. Kaufman, C. D. Langefeld, J. B. Harley et al., “Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus,” The Journal of Rheumatology, vol. 39, no. 6, pp. 1238–1240, 2012. View at Publisher · View at Google Scholar
  3. D. Koffler, V. Agnello, R. I. Carr, and H. G. Kunkel, “Anti-DNA antibodies and renal lesions of patients with systemic lupus erythematosus,” Transplantation Proceedings, vol. 1, no. 4, pp. 933–938, 1969. View at Google Scholar · View at Scopus
  4. C. E. Weckerle, B. S. Franek, J. A. Kelly et al., “Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 63, no. 4, pp. 1044–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. B. Niewold, J. Hua, T. J. A. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes and Immunity, vol. 8, no. 6, pp. 492–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. S. Ramos, J. A. Kelly, C. Gray-McGuire et al., “Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus,” Genes and Immunity, vol. 7, no. 5, pp. 417–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” The New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. B. Niewold, D. N. Clark, R. Salloum, and B. D. Poole, “Interferon alpha in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 948364, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. B. Niewold, “Interferon alpha-induced lupus: proof of principle,” Journal of Clinical Rheumatology, vol. 14, no. 3, pp. 131–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. B. Niewold and W. I. Swedler, “Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C,” Clinical Rheumatology, vol. 24, no. 2, pp. 178–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. S. N. Kariuki and T. B. Niewold, “Genetic regulation of serum cytokines in systemic lupus erythematosus,” Translational Research, vol. 155, no. 3, pp. 109–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Salloum and T. B. Niewold, “Interferon regulatory factors in human lupus pathogenesis,” Translational Research, vol. 157, no. 6, pp. 326–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. B. Niewold, “Interferon alpha as a primary pathogenic factor in human lupus,” Journal of Interferon & Cytokine Research, vol. 31, no. 12, pp. 887–892, 2011. View at Publisher · View at Google Scholar
  14. T. B. Niewold, J. A. Kelly, S. N. Kariuki, B. S. Franek, A. A. Kumar, K. M. Kaufman et al., “IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 71, no. 3, pp. 463–469, 2012. View at Publisher · View at Google Scholar
  15. S. N. Kariuki, K. A. Kirou, E. J. MacDermott, L. Barillas-Arias, M. K. Crow, and T. B. Niewold, “Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-α in lupus patients in vivo,” The Journal of Immunology, vol. 182, no. 1, pp. 34–38, 2009. View at Google Scholar · View at Scopus
  16. R. Salloum, B. S. Franek, S. N. Kariuki et al., “Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-α activity in lupus patients,” Arthritis & Rheumatism, vol. 62, no. 2, pp. 553–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Agik, B. S. Franek, A. A. Kumar, M. Kumabe, T. O. Utset, R. A. Mikolaitis et al., “The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes,” The Journal of Rheumatology, vol. 39, no. 1, pp. 73–78, 2012. View at Publisher · View at Google Scholar
  18. T. Robinson, S. N. Kariuki, B. S. Franek, M. Kumabe, A. A. Kumar, M. Badaracco et al., “Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-{alpha} and serologic autoimmunity in lupus patients,” The Journal of Immunology, vol. 187, no. 3, pp. 1298–1303, 2011. View at Publisher · View at Google Scholar
  19. S. N. Kariuki, B. S. Franek, A. A. Kumar et al., “Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 12, no. 4, article R151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. N. Kariuki, B. S. Franek, R. A. Mikolaitis et al., “Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 826434, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. R. Gamazon, W. Zhang, A. Konkashbaev et al., “SCAN: SNP and copy number annotation,” Bioinformatics, vol. 26, no. 2, pp. 259–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. L. Nicolae, E. Gamazon, W. Zhang, S. Duan, M. E. Dolan, and N. J. Cox, “Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS,” PLoS Genetics, vol. 6, no. 4, Article ID e1000888, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Tan, A. S. Cohen, J. F. Fries et al., “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis & Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Google Scholar · View at Scopus
  24. J. Hua, K. Kirou, C. Lee, and M. K. Crow, “Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies,” Arthritis & Rheumatism, vol. 54, no. 6, pp. 1906–1916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. T. B. Niewold, T. L. Rivera, J. P. Buyon, and M. K. Crow, “Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus,” Arthritis & Rheumatism, vol. 58, no. 2, pp. 541–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. B. Niewold, S. N. Kariuki, G. A. Morgan, S. Shrestha, and L. M. Pachman, “Elevated serum interferon-α activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy,” Arthritis & Rheumatism, vol. 60, no. 6, pp. 1815–1824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Feng, N. P. Reder, M. Yanamandala, A. Hill, B. S. Franek, T. B. Niewold et al., “Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis,” Journal of the Neurological Sciences, vol. 313, no. 1-2, pp. 48–53, 2012. View at Publisher · View at Google Scholar
  28. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Sanchez, M. E. Comeau, B. I. Freedman, J. A. Kelly, K. M. Kaufman, C. D. Langefeld et al., “Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study,” Arthritis & Rheumatism, vol. 63, no. 11, pp. 3493–3501, 2011. View at Publisher · View at Google Scholar
  30. J. P. Lodolce, L. E. Kolodziej, L. Rhee et al., “African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity,” The Journal of Immunology, vol. 184, no. 12, pp. 7001–7009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Pothlichet, T. B. Niewold, D. Vitour, B. Solhonne, M. K. Crow, and M. Si-Tahar, “A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients,” EMBO Molecular Medicine, vol. 3, no. 3, pp. 142–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. A. Tishkoff, F. A. Reed, A. Ranciaro et al., “Convergent adaptation of human lactase persistence in Africa and Europe,” Nature Genetics, vol. 39, no. 1, pp. 31–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. I. T. W. Harley, T. B. Niewold, R. M. Stormont, K. M. Kaufman, S. B. Glenn, B. S. Franek et al., “The role of genetic variation near interferon-kappa in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 706825, 11 pages, 2010. View at Publisher · View at Google Scholar
  34. T. Trivedi, B. S. Franek, S. L. Green, S. N. Kariuki, M. Kumabe, R. A. Mikolaitis et al., “Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 802581, 6 pages, 2011. View at Publisher · View at Google Scholar
  35. C. E. Weckerle and T. B. Niewold, “The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies,” Clinical Reviews in Allergy and Immunology, vol. 40, no. 1, pp. 42–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Sanchez, A. Nadig, B. C. Richardson, B. I. Freedman, K. M. Kaufman, J. A. Kelly et al., “Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 70, no. 10, pp. 1752–1757, 2011. View at Publisher · View at Google Scholar
  37. C. E. Weckerle, D. Imbuka, B. S. Franek, J. A. Kelly, M. Kumabe, J. A. James et al., “Large scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus,” Arthritis Rheum, vol. 64, no. 9, pp. 2947–2952, 2012. View at Publisher · View at Google Scholar
  38. L. L. Ritterhouse, S. R. Crowe, T. B. Niewold, J. T. Merrill, V. C. Roberts, A. B. Dedeke et al., “B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels,” Arthritis & Rheumatism, vol. 63, no. 12, pp. 3931–3941, 2011. View at Publisher · View at Google Scholar
  39. R. R. Graham, S. V. Kozyrev, E. C. Baechler et al., “A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus,” Nature Genetics, vol. 38, no. 5, pp. 550–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Sigurdsson, H. H. H. Göring, G. Kristjansdottir et al., “Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus,” Human Molecular Genetics, vol. 17, no. 6, pp. 872–881, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Padyukov, M. Seielstad, R. T. H. Ong et al., “A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 2, pp. 259–265, 2011. View at Publisher · View at Google Scholar · View at Scopus